Adrenergic receptors in rat spinal cord

D. J. Jones; D. E. Kendall; S. J. Enna

doi:10.1016/0028-3908(82)90162-9

Adrenergic receptors in rat spinal cord

D. J. Jones, D. E. Kendall, S. J. Enna

Anesthesiology

Research output: Contribution to journal › Article

35 Scopus citations

Abstract

Radioligand binding assays were used to demonstrate the presence of α₁, α(2) and β receptora in rat spinal cord. Specific and saturable binding was exhibited for [³H-WB 4101 (α₁), [³H]-aminoclonldine (α₂) and [³H]-dihydroalprenolol(β). Binding was of high affinity and the total number of binding sites (B_maxwere: α₁, 66.5 ± 1.0 fmol/mg protein; α₂, 20.0 ± 0.6 fmol/mg protein; β, 10.2 ± 0.3 fmol/mg protein. The data confirms the existence of adrenergic receptors in spinal cord and provides further evidence of the role of catecholaminergic neurons in regulating spinal cord physiology.

Original language	English (US)
Pages (from-to)	191-195
Number of pages	5
Journal	Neuropharmacology
Volume	21
Issue number	2
DOIs	https://doi.org/10.1016/0028-3908(82)90162-9
State	Published - Feb 1982

ASJC Scopus subject areas

Pharmacology
Cellular and Molecular Neuroscience

Access to Document

10.1016/0028-3908(82)90162-9

Fingerprint Dive into the research topics of 'Adrenergic receptors in rat spinal cord'. Together they form a unique fingerprint.

Cite this

Jones, D. J., Kendall, D. E., & Enna, S. J. (1982). Adrenergic receptors in rat spinal cord. Neuropharmacology, 21(2), 191-195. https://doi.org/10.1016/0028-3908(82)90162-9

@article{5c38f2c961c947958a0a1e30c2503a45,

title = "Adrenergic receptors in rat spinal cord",

abstract = "Radioligand binding assays were used to demonstrate the presence of α1, α(2) and β receptora in rat spinal cord. Specific and saturable binding was exhibited for [3H-WB 4101 (α1), [3H]-aminoclonldine (α2) and [3H]-dihydroalprenolol(β). Binding was of high affinity and the total number of binding sites (Bmaxwere: α1, 66.5 ± 1.0 fmol/mg protein; α2, 20.0 ± 0.6 fmol/mg protein; β, 10.2 ± 0.3 fmol/mg protein. The data confirms the existence of adrenergic receptors in spinal cord and provides further evidence of the role of catecholaminergic neurons in regulating spinal cord physiology.",

author = "Jones, {D. J.} and Kendall, {D. E.} and Enna, {S. J.}",

year = "1982",

month = feb,

doi = "10.1016/0028-3908(82)90162-9",

language = "English (US)",

volume = "21",

pages = "191--195",

journal = "Neuropharmacology",

issn = "0028-3908",

publisher = "Elsevier Limited",

number = "2",

}

TY - JOUR

T1 - Adrenergic receptors in rat spinal cord

AU - Jones, D. J.

AU - Kendall, D. E.

AU - Enna, S. J.

PY - 1982/2

Y1 - 1982/2

N2 - Radioligand binding assays were used to demonstrate the presence of α1, α(2) and β receptora in rat spinal cord. Specific and saturable binding was exhibited for [3H-WB 4101 (α1), [3H]-aminoclonldine (α2) and [3H]-dihydroalprenolol(β). Binding was of high affinity and the total number of binding sites (Bmaxwere: α1, 66.5 ± 1.0 fmol/mg protein; α2, 20.0 ± 0.6 fmol/mg protein; β, 10.2 ± 0.3 fmol/mg protein. The data confirms the existence of adrenergic receptors in spinal cord and provides further evidence of the role of catecholaminergic neurons in regulating spinal cord physiology.

AB - Radioligand binding assays were used to demonstrate the presence of α1, α(2) and β receptora in rat spinal cord. Specific and saturable binding was exhibited for [3H-WB 4101 (α1), [3H]-aminoclonldine (α2) and [3H]-dihydroalprenolol(β). Binding was of high affinity and the total number of binding sites (Bmaxwere: α1, 66.5 ± 1.0 fmol/mg protein; α2, 20.0 ± 0.6 fmol/mg protein; β, 10.2 ± 0.3 fmol/mg protein. The data confirms the existence of adrenergic receptors in spinal cord and provides further evidence of the role of catecholaminergic neurons in regulating spinal cord physiology.

UR - http://www.scopus.com/inward/record.url?scp=0020071901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020071901&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(82)90162-9

DO - 10.1016/0028-3908(82)90162-9

M3 - Article

C2 - 6278360

AN - SCOPUS:0020071901

VL - 21

SP - 191

EP - 195

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 2

ER -